Do anti-inflammatory drugs delay disability in secondary progressive MS? 

Disappointingly, formal clinical trials have failed to show any efficacy of the drugs for relapsing remitting MS (RRMS), in slowing disability progression specifically in people with secondary progressive MS (SPMS).

Despite this, many people continue to use these anti-inflammatory drugs even after the transition to SPMS, despite the lack of strong evidence for any benefit.

In a recent study published in the scientific journal Neurology an international team of researchers have used the very powerful international observational clinical database known as MSBase to further examine, in a real-world setting outside…

Favicon of da :

Prosegui la lettura...
Traduci l'articolo...

Sclerosi Multipla News

Potrebbe interessarti anche

Argomenti correlati